{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:12:25Z","timestamp":1791645145152,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40618-020-01353-y","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T17:07:45Z","timestamp":1594314465000},"page":"581-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves\u2019 orbitopathy"],"prefix":"10.1007","volume":"44","author":[{"given":"F.","family":"Nicol\u00ec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lanzolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mantuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sframeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Posarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Maglionico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Figus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-116X","authenticated-orcid":false,"given":"M.","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"1353_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves\u2019 Orbitopathy (EUGOGO) (2016) The 2016 European thyroid association\/european group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"key":"1353_CR2","first-page":"444","volume":"36","author":"E Piantanida","year":"2013","unstructured":"Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century. J Endocrinol Invest 36:444\u2013449","journal-title":"J Endocrinol Invest"},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/thy.2014.0475","volume":"25","author":"M Leo","year":"2015","unstructured":"Leo M, Menconi F, Rocchi R, Latrofa F, Sisti E, Profilo MA, Mazzi B, Albano E, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2015) Role of the underlying thyroid disease on the phenotype of graves\u2019 orbitopathy in a tertiary referral center. Thyroid 25:347\u2013351","journal-title":"Thyroid"},{"key":"1353_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362:726\u2013738","journal-title":"N Engl J Med"},{"key":"1353_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn RS (2015) Current insights into the Pathogenesis of Graves\u2019 Ophthalmopathy. Horm Metab Res 47:773\u2013778","journal-title":"Horm Metab Res"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF03345271","volume":"27","author":"M Marin\u00f2","year":"2004","unstructured":"Marin\u00f2 M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A (2004) Role of thyroglobulin in the pathogenesis of Graves\u2019 ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 27:230\u2013236","journal-title":"J Endocrinol Invest"},{"key":"1353_CR7","first-page":"998","volume":"83","author":"RS Bahn","year":"1998","unstructured":"Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE (1998) Thyrotropin receptor expression in Graves\u2019 orbital adipose\/connective tissues: potential autoantigen in Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 83:998\u20131002","journal-title":"J Clin Endocrinol Metab"},{"key":"1353_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/thy.1998.8.411","volume":"8","author":"M Ludgate","year":"1998","unstructured":"Ludgate M, Crisp M, Lane C et al (1998) The thyrotropin receptor in thyroid eye disease. Thyroid 8:411\u2013413","journal-title":"Thyroid"},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/thy.1998.8.193","volume":"8","author":"RS Bahn","year":"1998","unstructured":"Bahn RS, Dutton CM, Joba W, Heufelder AE (1998) Thyrotropin receptor expression in cultured Graves\u2019 orbital preadipocyte fibroblasts is stimulated by thyrotropin. Thyroid 8:193\u2013196","journal-title":"Thyroid"},{"key":"1353_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","volume":"58","author":"IMMJ Wakelkamp","year":"2003","unstructured":"Wakelkamp IMMJ, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF (2003) TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients. Clin Endocrinol (Oxf) 58:280\u2013287","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1353_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/JME-11-0006","volume":"46","author":"S Kumar","year":"2011","unstructured":"Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS (2011) A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves\u2019 ophthalmopathy. J Mol Endocrinol 46:155\u2013163","journal-title":"J Mol Endocrinol"},{"key":"1353_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding MN, Van Der Meer JWC, Broenink M, Bakker O, Wiersinga WM, Prummel MF et al (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 52:267\u2013271","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1353_CR13","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1210\/jc.2009-2470","volume":"95","author":"SD Lytton","year":"2010","unstructured":"Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ (2010) A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of graves\u2019 orbitopathy. J Clin Endocrinol Metab 95:2123\u20132131","journal-title":"J Clin Endocrinol Metab"},{"key":"1353_CR14","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H et al (2006) Thyrotropin receptor autoantibodies are independent risk factors for graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91:3464\u20133470","journal-title":"J Clin Endocrinol Metab"},{"key":"1353_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/thy.2000.10.809","volume":"10","author":"JY Noh","year":"2000","unstructured":"Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K (2000) Thyroid-stimulating antibody is related to Graves\u2019 ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves\u2019 disease. Thyroid 10:809\u2013813","journal-title":"Thyroid"},{"key":"1353_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1507\/endocrj.EJ15-0137","volume":"63","author":"K Mukasa","year":"2016","unstructured":"Mukasa K, Noh JY, Kouzaki A et al (2016) TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves\u2019 ophthalmopathy in untreated Japanese Graves\u2019 disease patients. Endocr J 63:151\u2013157","journal-title":"Endocr J"},{"key":"1353_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3341\/kjo.2015.29.4.213","volume":"29","author":"YJ Woo","year":"2015","unstructured":"Woo YJ, Jang SY, Lim THT, Yoon JS (2015) Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves\u2019 orbitopathy. Korean J Ophthalmol 29:213\u2013219","journal-title":"Korean J Ophthalmol"},{"key":"1353_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40618-018-0945-6","volume":"41","author":"S Seo","year":"2018","unstructured":"Seo S, S\u00e1nchez Robledo M (2018) Usefulness of TSH receptor antibodies as biomarkers for Graves\u2019 ophthalmopathy: a systematic review. J Endocrinol Invest 41:1457\u20131468","journal-title":"J Endocrinol Invest"},{"key":"1353_CR19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/cen.13327","volume":"86","author":"A Hesarghatta Shyamasunder","year":"2017","unstructured":"Hesarghatta Shyamasunder A, Abraham P (2017) Measuring TSH receptor antibody to influence treatment choices in Graves\u2019 disease. Clin Endocrinol (Oxf) 86:652\u2013657","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1353_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.autrev.2010.08.018","volume":"10","author":"SD Lytton","year":"2010","unstructured":"Lytton SD, Kahaly GJ (2010) Bioassays for TSH-receptor autoantibodies: an update. Autoimmun Rev 10:116\u2013122","journal-title":"Autoimmun Rev"},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000375445","volume":"4","author":"GJ Kahaly","year":"2015","unstructured":"Kahaly GJ (2015) Bioassays for TSH receptor antibodies: quo vadis? Eur Thyroid J 4:3\u20135","journal-title":"Eur Thyroid J"},{"key":"1353_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","volume":"10","author":"DH Khoo","year":"2000","unstructured":"Khoo DH, Eng PH, Ho SC et al (2000) Graves\u2019 ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 10:1093\u20131100","journal-title":"Thyroid"},{"key":"1353_CR23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/jc.2016-1220","volume":"101","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly GJ, Diana T, Glang J, Kanitz M, Pitz S, K\u00f6nig J (2016) Thyroid stimulating antibodies are highly prevalent in Hashimoto\u2019s thyroiditis and associated orbitopathy. J Clin Endocrinol Metab 101:1998\u20132004","journal-title":"J Clin Endocrinol Metab"},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/01676830490504089","volume":"23","author":"MP Mourits","year":"2004","unstructured":"Mourits MP, Lombardo SHC, Van Der Sluijs FA, Fenton S (2004) Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves\u2019 patients. An exploratory study. Orbit 23:161\u2013168","journal-title":"Orbit"},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/thy.2006.0279","volume":"17","author":"H Bilen","year":"2007","unstructured":"Bilen H, Gullulu G, Akcay G (2007) Exophthalmometric values in a normal Turkish population living in the northeastern part of Turkey. Thyroid 17:525\u2013528","journal-title":"Thyroid"},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/OPX.0b013e3181890dc7","volume":"85","author":"MB Kashkouli","year":"2008","unstructured":"Kashkouli MB, Nojomi M, Parvaresh MM, Sanjari MS, Modarres M, Noorani MM (2008) Normal values of hertel exophthalmometry in children, teenagers, and adults from Tehran. Iran Optom Vis Sci 85:1012\u20131017","journal-title":"Iran Optom Vis Sci"},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/112067210801800201","volume":"18","author":"\u00dc Beden","year":"2008","unstructured":"Beden \u00dc, \u00d6zarslan Y, \u00d6zt\u00fcrk HE, S\u00f6nmez B, Erkan D, Oge I (2008) Exophthalmometry values of Turkish adult population and the effect of age, sex, refractive status, and Hertel base values on Hertel readings. Eur J Ophthalmol 18:165\u2013171","journal-title":"Eur J Ophthalmol"},{"key":"1353_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1442-9071.2009.02087.x","volume":"37","author":"WO Chan","year":"2009","unstructured":"Chan WO, Madge SN, Senaratne T et al (2009) Exophthalmometric values and their biometric correlates: the Kandy eye study. Clin Exp Ophthalmol 37:496\u2013502","journal-title":"Clin Exp Ophthalmol"},{"key":"1353_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/thy.2012.0379","volume":"23","author":"MA Profilo","year":"2013","unstructured":"Profilo MA, Sisti E, Marcocci C et al (2013) Thyroid volume and severity of graves\u2019 orbitopathy. Thyroid 23:97\u2013102","journal-title":"Thyroid"},{"key":"1353_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A et al (2008) Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273\u2013285","journal-title":"Eur J Endocrinol"},{"key":"1353_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47:9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1353_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","volume":"26","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ (2012) Evaluating Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 26:229\u2013248","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1353_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","volume":"22","author":"PJ Dolman","year":"2006","unstructured":"Dolman PJ, Rootman J (2006) VISA classification for graves orbitopathy. Ophthal Plast Reconstr Surg 22:319\u2013324","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1353_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.1991.1.357","volume":"1","author":"WM Wiersinga","year":"1991","unstructured":"Wiersinga WM, Prummel MF, Mourits MP, Koornneef L, Buller HR (1991) Classification of the eye changes of Graves\u2019 disease. Thyroid 1:357\u2013360","journal-title":"Thyroid"},{"key":"1353_CR35","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","volume":"118","author":"KA Ponto","year":"2011","unstructured":"Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in Graves\u2019 ophthalmopathy. Ophthalmology 118:2279\u20132285","journal-title":"Ophthalmology"},{"key":"1353_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3349\/ymj.2013.54.4.1033","volume":"54","author":"SY Jang","year":"2013","unstructured":"Jang SY, Shin DY, Lee EJ, Choi YJ, Lee SY, Yoon JS (2013) Correlation between TSH receptor antibody assays and clinical manifestations of Graves\u2019 orbitopathy. Yonsei Med J 54:1033\u20131039","journal-title":"Yonsei Med J"},{"key":"1353_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40618-019-01094-7","volume":"43","author":"M Rotondi","year":"2020","unstructured":"Rotondi M, Virili C, Pinto S et al (2020) The clinical phenotype of Graves\u2019 disease occurring as an isolated condition or in association with other autoimmune diseases. J Endocrinol Invest 43:157\u2013162","journal-title":"J Endocrinol Invest"},{"key":"1353_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"Menconi F, Profilo MA, Leo M et al (2014) Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited. Thyroid 24:60\u201366","journal-title":"Thyroid"},{"key":"1353_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40618-019-01116-4","volume":"43","author":"YP Hai","year":"2019","unstructured":"Hai YP, Lee ACH, Frommer L, Diana T, Kahaly GJ (2019) Immonoistochemical analysis of human orbital tissue in Graves\u2019 orbitopathy. J Endocrinol Invest 43:123\u2013137","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:26:17Z","timestamp":1625786777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01353-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"13 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedure performed in the study involving human participants were in accordance with the ethical standards of the Trust and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}